default author photo

Sang Wun Kim

Yonsei University - Department of Obstetrics and Gynecology

SCHOLARLY PAPERS

3

DOWNLOADS

126

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Efficacy and Safety of Triplet Maintenance Therapy (Olaparib, Pembrolizumab, And Bevacizumab) in BRCA Non-Mutated Patients with Platinum-Sensitive Recurrent Ovarian Cancer: A Multi-Centre, Single-Arm Phase II Study (OPEB-01/APGOT-OV4/MK 3475-B32)

Number of pages: 28 Posted: 21 Oct 2022
Yonsei University - Department of Obstetrics and Gynecology, Sungkyunkwan University - Biomedical Statistics Center, Seoul National University - Department of Obstetrics and Gynecology, Sungkyunkwan University - Department of Obstetrics and Gynecology, Yonsei University - Department of Obstetrics and Gynecology, Seoul National University - Department of Obstetrics and Gynecology, Sungkyunkwan University - Samsung Medical Center, Chinese Academy of Medical Sciences - Center for Gynecologic CancerNational Cancer Center, Korea - Center for Gynecologic Cancer, National University Health System (NUHS) - National University Cancer Institute, National University Health System (NUHS) - National University Cancer Institute and Yonsei University - Department of Obstetrics and Gynecology
Downloads 76 (830,357)

Abstract:

Loading...

Ovarian Neoplasms, Platinum-resistant, BRCA wild type, PARP inhibitor, Immunotherapy

2.

Efficacy of Chemotherapy Following Prior Parp-Inhibitor Treatment in Patients with Ovarian Cancer

Number of pages: 26 Posted: 19 Jun 2024
affiliation not provided to SSRN, Yonsei University - Department of Obstetrics and Gynecology, Yonsei University - College of Medicine, affiliation not provided to SSRN, Yonsei University - Gangnam Severance Hospital, Yonsei University - Department of Obstetrics and Gynecology, Yonsei University - College of Medicine, Yonsei University, Seoul National University - Department of Obstetrics and Gynecology, Seoul National University - Seoul National University Hospital and Sungkyunkwan University - Samsung Medical Center
Downloads 30 (1,317,895)

Abstract:

Loading...

Ovarian cancer, PARP inhibitor, Prognosis, recurrence, Survival

3.

Stereotactic Ablative Body Radiotherapy May Enhance Outcomes in Oligometastatic Uterine Cervical Cancer

Number of pages: 20 Posted: 17 Apr 2025
Yonsei University - Department of Radiation Oncology, Yonsei University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Yonsei University - Department of Obstetrics and Gynecology, Yonsei University - Gangnam Severance Hospital, Yonsei University - Department of Obstetrics and Gynecology, Yonsei University - College of Medicine and Yonsei University
Downloads 20 (1,447,679)

Abstract:

Loading...

Uterine Cervical Neoplasms, Oligometastasis, Stereotactic Ablative Body Radiotherapy, Programmed Cell Death Ligand 1